Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Sinsin Pharmaceutical Revenue

Sinsin Pharmaceutical had revenue of 34.00B KRW in the quarter ending June 30, 2026, with 14.88% growth. This brings the company's total for the last twelve months to 123.05B, up 14.86% year-over-year. In the year 2025, Sinsin Pharmaceutical had annual revenue of 113.78B with 6.95% growth. That makes Sinsin Pharmaceutical the 23,213th largest company in the world by revenue and 1,319th in South Korea.

• Revenue (ttm): 123.05B
• Revenue Growth: +14.86%
• P/S Ratio: 0.50
• Revenue / Employee: 335.29M
• Employees: 367
• Market Cap: 61.90B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 98.24B 86.3%
• Export 15.54B 13.7%

Fiscal year ended Dec 31, 2025 See the full Sinsin Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	113.78B	7.39B	6.95%
Dec 31, 2024	106.39B	3.80B	3.71%
Dec 31, 2023	102.59B	10.66B	11.60%
Dec 31, 2022	91.93B	17.92B	24.21%
Dec 31, 2021	74.01B	6.88B	10.25%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error